Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating abatacept for moderate-to-severe alopecia areata has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Columbia University | Conditions: Alopecia Areata | Phase 2 | Status: WITHDRAWN